THE use of sleeping tablets has recently been the subject of much discussion and controversy. Criticism of their use has been based on doubts about their value and their adverse reactions.
THE VALUE OF HYPNOTICS
The value of all medication for sleep has been called into question. Although current research is adding to our knowledge of what happens to the brain, the circulation and the endocrine system during sleep, we are ignorant of how much sleep is needed and what processes need to go on during sleep. There is evidence (Oswald 1973 ) that hypnotics interfere with the physiological features of normal sleep and that their effects on the performance of skilled tasks persist during the following day and possibly for several days. It has been shown that some patients who take a hypnotic at night are abnormally restless in the early hours of the following morning and that nocturnal restlessness is common for many nights after stopping sleeping tablets after more than a few days of regular use. This restlessness may convince patients, and doctors, that medication should be restarted and is a major factor in perpetuating the use of hypnotics.
THE ADVERSE REACTIONS OF HYPNOTICS
Barbiturates which were the choice in 80 per cent of prescriptions written for hypnotics fifteen years ago, have been the subject of critical comment in recent years (B.M.J. Leading Article, 1975 : Wells, 1975 . They may lead to dependence and they can cause serious withdrawal symptoms. They have in some parts of the United Kingdom become drugs of abuse, popular with teenagers and those who wish to potentiate the effects of alcohol. They have become commonly used drugs for self poisoning either to draw attention to distress or to commit suicide. Because of the evidence of their misuse the Campaign for the Use and Restriction of Barbiturates (C.U.R.B.) was launched in 1975 to reduce the prescribing and availability of barbiturates. Barbiturates have also been criticised, although other hypnotics are probably just as bad, because in elderly patients with reduced cerebral reserves, they often cause confusion at night and uns'eadiness and drowsiness the following day. They are potent inducers of hepatic enzymes and interfere with the metabolism of many drugs, especially the anticoagulants.
It has been widely recommended that other hypno. ics should be substituted for the barbiturates. Of those currently available the benzodiazepines seem the best: they do not induce hepatic enzymes, are not so liable to cause serious dependence and are seldom dangerous in overdose. However, even nitrazepam (Mogadon) has not been in use long enough to assess its disadvantages when widely used in a community. Chloral and its derivatives (Noctec, Tricloryl, Welldorm) all induce hepatic enzymes and are gastric irritants causing dyspepsia. Methaqualone, either alone (Melsedin, Revonal) or in combination with diphenhydramine (Mandrax) also induces hepatic enzymes. Moreover, Mandrax has been widely misused, and overdose, especially if combined with alcohol, is danigerous and often difficult to trea'. Glutethimide (Doriden) another enzyme inducer, occasionally causes neuropathy. All daily doses". Details of the methods used in the survey and the basis on which daily doses of drugs are agreed are given in the first paper of this series (Elmes, Hood and Wade, 1976 Although the use of hypnotics has increased since 1966, the geographical distribution of high and low prescribing has remained constant and the prescribing of hypnotics has not been rela'ed either temporarily or geographically to the level of civil strife which broke out in 1969 and has persisted sporadically in some areas of Northern Ireland ever since. In 1973 a reorganisation of the health services took place and data on the prescribing of hypnotics in 1974 is available for the new Health Services Districts. The variations in prescribing be:ween these 17 districts (Table 2 ) are greater than was found between the previous counties and Mogadon was used less than Mandrax at first but the rate of prescribing of this drug has increased and is still increasing so that in 1974, it equalled that of all the barbiturates, 20 daily doses/1,000/day. This increased prescribing of Mogadon has probably been partly due to the adverse publicity given first to Mandrax and now to the barbiturates.
Although the prescribing of hypnotics varies very greatly from county to county (Fig. 2) , the increase in the use of Mogadon and the decrease in the use of barbiturates has occurred in all areas, both where the prescribing of hypnotics was high as in Belfast or low as in Londonderry.
DIFFERENCES BETWEEN DOCTORS
The average figures for prescribing in counties or administrative districts conceal the great variations that exist in the prescribing habits of individual doctors. These differences are demonstrated in a survey of the prescribing habits of five selected groups of doctors in 1972, 1973 and 1974 . Their prescribing has been compared with the average prescribing for the whole province during those years (Table 3) . Group I was a control group of doctors in 19 practices chosen because their total use of hypnotics in 1972 was the same as the average of the whole province. Seven of the practices were in Belfast, three in Co. Down, two in Co. Armagh, three in Co. Antrim and two in Co. Londonderry. The pattern of prescribing of this group was similar to the average of the whole province except that they were rather higher prescribers of Mandrax. Over the 3 years the proportion of their prescriptions written for barbiturates and Mandrax fell from 44 per cent and 19 per cent respectively to 39 per cent and 7 per cent. The proportion of prescriptions for Mogadon rose from 35 per cent to 48 per cent so becoming similar to the provincial average. It was found that the large practices and those with 1,900-2,300 patients/ doctor prescribed 39.5 and 37.7 daily doses!1,000/day of hypnotic drugs respectively which was not significantly different from the province as a whole. In the 26 small practices the prescribing was twice as high, 78.3 daily doses!1,000/day (P<0.05 using the paired T test).
INTERNATIONAL COMPARISONS
The prescribing of hypnotics in Northern Ireland has been compared with the prescribing of these drugs in Norway where the data is derived from information about the supply of drugs on prescription by pharmacists of the state drug monopoly, Norsk Medicinaldepo+, to the community. For this comparison, phenobarbitone is added to the Northern Ireland figures because it is used in Norway In the Norwegian data, phenobarbitone is included as it has a significant use as a hypnotic. For the sake of an exact comparison phenobarbitone has been included in the construction of the Northern Ireland graph for Fig. 3 , but because it is not used significantly as a hypnotic in Northern Ireland, it is excluded from Fig. 1 and Fig. 2 Detailed information about the doses of hypnotics prescribed by individual doctors or practices in relation to the number of people in the community is not yet available from England. However, the number of prescriptions written per 1,000 of the population can be estimated and in Fig. 4 is compared with similar data from Northern Ireland. The prescribing of all hypnotics and of the barbiturates was higher in England than in Northern Ireland in 1966. It has fallen steadily since that time and in 1973, the number of prescriptions per 1,000 persons/day, was similar in the two countries for all hypnotics, for barbiturate hypnotics and for non-barbiturate hypnotics.
FIG. 4 Comparisons between Northern Ireland and England by
Number of Prescriptions Although there are great variations from practitioner to practitioner in their prescribing of hypnotics, an individual practitioner seems to persist in his prescribing habits, the high prescriber remaining a high prescriber and the low remaining a low prescriber even though their choice of hypnotic drugs changes.
Indeed, there has been a decrease in the use of barbiturates and a marked increase in the prescribing of nitrazepam (Mogadon) a benzodiazepine and this change is apparent in the prescribing of all doc ors whether high or low prescribers of hypnotics. Mandrax and other non-barbiturate hypnotics apart from Mogadon have become less popular in the last few years.
It is not difficult to understand why there is such great variation in the prescribing of sleeping tablets. The complaint of sleeplessness is subjective and a doctor in deciding whether to prescribe for it or not relies partly on knowledge of the patient's character and partly on the vehemence of his complaints: there are no objective criteria on which he can rely. Indeed, the few studies which have been carried out, usually in hospitals or under laboratory conditions show that there is a very poor correlation between the complaints a patient makes of sleeplessness and the number of hours of sleep which are actually recorded. It is known too that the placebo effects of an impressive looking tablet or capsule may be considerable in the treatment of these complaints.
The findings of this survey suggest that the prescribing of sleeping tablets is not determined predominantly by the medical needs of patients. It is more likely that sleeping tablets are prescribed by dociors mainly in response to demands from patients and that these vary from area to area according to the social climate, the sophistication of the community, its concepts of what constitutes illness and its attitudes to drugs and drug taking. The doctor may be influenced by his training in medical school, his postgraduate experience and drug advertising but he too is probably greatly influenced by the attitudes to the use of drugs prevalent in his community. There is some evidence that doctors with small numbers of patients are more likely than others to accede to the demands of their patients.
If a rational policy for prescribing hypnotics is to be developed it is necessary to find out more than is at present known about patients who demand sleeping tablets, why they need them and what benefits or harm they derive from taking them. Yet even now the evidence already suggests that the long term effects of any hypnotic on sleep and cerebral activity are such that they should not be pre-scribed to any patient unless there is a very good reason and in any case for only a short period of time.
SUMMARY
The prescribing of sleeping tablets and medicines by Northern Ireland general practitioners has been analysed for the years [1966] [1967] [1968] [1969] [1970] [1971] [1972] [1973] [1974] . Total prescribing has risen from 30 daily doses per 1,000 of population per day to 44 daily doses, most of the increase occurring between 1966 and 1969. A combination of methaqualone and diphenhydramine was popular for several years until teenage abuse led doctors to reduce their prescribing. Prescribing of hypnotics is highest in a suburban area of Belfast and lowest in remo'e country areas, it bears no relationship to civil strife or to the age of the prescribing doctor. Doctors with small practices prescribe twice as much per 1,000 of their patients as doctors with average or large practices. All doctors have tended to replace barbiturates (which amounted to 80 per cent of hypnotic prescribing in 1966) by nitrazepam which now equals in volume the prescribing of all the barbiturate hypnotics added together. Comparisons are made with prescribing patterns in England and in Norway.
